{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:36:57Z","timestamp":1784266617090,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T00:00:00Z","timestamp":1566691200000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006190","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1306600"],"award-info":[{"award-number":["2016YFC1306600"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006190","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017ZX09304021"],"award-info":[{"award-number":["2017ZX09304021"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"publisher","award":["31671035"],"award-info":[{"award-number":["31671035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"publisher","award":["51473071"],"award-info":[{"award-number":["51473071"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"publisher","award":["21504034"],"award-info":[{"award-number":["21504034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"publisher","award":["81472749"],"award-info":[{"award-number":["81472749"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Medical Innovation Team","award":["CXTDA2017024"],"award-info":[{"award-number":["CXTDA2017024"]}]},{"DOI":"10.13039\/501100002949","name":"Jiangsu Province Foundation","doi-asserted-by":"publisher","award":["BK20161137"],"award-info":[{"award-number":["BK20161137"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Jiangsu Province Foundation","doi-asserted-by":"publisher","award":["BK20170204"],"award-info":[{"award-number":["BK20170204"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Jiangsu Province Foundation","doi-asserted-by":"publisher","award":["BE2016632"],"award-info":[{"award-number":["BE2016632"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Commission of Health and Family Planning Foundation","award":["H2017031"],"award-info":[{"award-number":["H2017031"]}]},{"name":"Wuxi Commission of Health and Family Planning Foundation","award":["Q201729"],"award-info":[{"award-number":["Q201729"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.brainres.2018.08.022","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T22:52:16Z","timestamp":1534978336000},"page":"213-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Age-related change of GLP-1R expression in rats can be detected by [18F]AlF-NOTA-MAL-Cys39-exendin-4"],"prefix":"10.1016","volume":"1698","author":[{"given":"Lizhen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runlin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.brainres.2018.08.022_b0005","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.parkreldis.2015.09.029","article-title":"Optimizing diagnosis in Parkinson\u2019s disease: radionuclide imaging","volume":"22","author":"Arena","year":"2016","journal-title":"Parkinsonism Relat. D"},{"issue":"10103","key":"10.1016\/j.brainres.2018.08.022_b0010","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","article-title":"Exenatide once weekly versus placebo in Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Athauda","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.brainres.2018.08.022_b0015","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","article-title":"The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson\u2019s disease: mechanisms of action","volume":"21","author":"Athauda","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.brainres.2018.08.022_b0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10787-017-0331-6","article-title":"Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson\u2019s disease","volume":"25","author":"Badawi","year":"2017","journal-title":"Inflammopharmacology"},{"issue":"6","key":"10.1016\/j.brainres.2018.08.022_b0025","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.brainres.2018.08.022_b0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.5056","article-title":"The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer\u2019s disease","volume":"245","author":"Batista","year":"2018","journal-title":"J. Pathol."},{"issue":"7288","key":"10.1016\/j.brainres.2018.08.022_b0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature08983","article-title":"Neural mechanisms of ageing and cognitive decline","volume":"464","author":"Bishop","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.brainres.2018.08.022_b0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrn3039","article-title":"Ageing as a primary risk factor for Parkinson\u2019s disease: evidence from studies of non-human primates","volume":"12","author":"Collier","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"10","key":"10.1016\/j.brainres.2018.08.022_b0045","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.molmet.2015.07.008","article-title":"Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain","volume":"4","author":"Cork","year":"2015","journal-title":"Mol. Metab."},{"issue":"12","key":"10.1016\/j.brainres.2018.08.022_b0050","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1172\/JCI97233","article-title":"Discovery, characterization, and clinical development of the glucagon-like peptides","volume":"127","author":"Drucker","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.brainres.2018.08.022_b0055","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-016-3874-y","volume":"59","author":"Farr","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.brainres.2018.08.022_b0060","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.2009.05118.x","article-title":"The progression of pathology in Parkinson\u2019s disease","volume":"1184","author":"Halliday","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.brainres.2018.08.022_b0065","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrd.2017.178","article-title":"Trends in GPCR drug discovery: new agents, targets and indications","volume":"16","author":"Hauser","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.brainres.2018.08.022_b0070","doi-asserted-by":"crossref","first-page":"T31","DOI":"10.1530\/JOE-13-0221","article-title":"Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases","volume":"221","author":"Holscher","year":"2014","journal-title":"J. Endocrinol."},{"issue":"11","key":"10.1016\/j.brainres.2018.08.022_b0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneurol.2017.140","article-title":"Parkinson disease: exenatide \u2013 a drug for diabetes and Parkinson disease?","volume":"13","author":"Jankovic","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.brainres.2018.08.022_b0080","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.25103","article-title":"Striatal dopamine in Parkinson disease: a meta-analysis of imaging studies","volume":"82","author":"Kaasinen","year":"2017","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.brainres.2018.08.022_b0085","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00259-011-1980-0","article-title":"18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma","volume":"39","author":"Kiesewetter","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.brainres.2018.08.022_b0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2015.06.054","article-title":"Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"303","author":"Liu","year":"2015","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.brainres.2018.08.022_b0095","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/jnc.13169","article-title":"Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice","volume":"135","author":"Li","year":"2015","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.brainres.2018.08.022_b0100","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/mds.21433","article-title":"Mild Parkinsonian signs: an overview of an emerging concept","volume":"22","author":"Louis","year":"2007","journal-title":"Movement Disord."},{"issue":"5","key":"10.1016\/j.brainres.2018.08.022_b0105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2967\/jnumed.115.167445","article-title":"Glucagon-like peptide-1 receptor PET\/CT with 68Ga-NOTA-exendin-4 for detecting localized insulinoma: a prospective cohort study","volume":"57","author":"Luo","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.brainres.2018.08.022_b0110","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00726-014-1718-y","article-title":"A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging","volume":"46","author":"Pan","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.brainres.2018.08.022_b0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","article-title":"Ageing and Parkinson\u2019s disease: why is advancing age the biggest risk factor?","volume":"14","author":"Reeve","year":"2014","journal-title":"Ageing Res. Rev."},{"issue":"6","key":"10.1016\/j.brainres.2018.08.022_b0120","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","article-title":"Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis","volume":"86","author":"Rizzo","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.brainres.2018.08.022_b0125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/acel.12312","article-title":"Parkinson\u2019s disease as a result of aging","volume":"14","author":"Rodriguez","year":"2015","journal-title":"Aging Cell"},{"issue":"15","key":"10.1016\/j.brainres.2018.08.022_b0130","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1212\/WNL.0000000000003810","article-title":"Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease","volume":"88","author":"Saari","year":"2017","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.brainres.2018.08.022_b0135","doi-asserted-by":"crossref","first-page":"21513","DOI":"10.3390\/ijms141121513","article-title":"Neuroprotective effects of liraglutide for stroke model of rats","volume":"14","author":"Sato","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.brainres.2018.08.022_b0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA-Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.brainres.2018.08.022_b0145","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10571-012-9900-9","article-title":"Therapeutic potential of N-acetyl-glucagon-like peptide-1 in primary motor neuron cultures derived from non-transgenic and SOD1-G93A ALS mice","volume":"33","author":"Sun","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"issue":"8\u20139","key":"10.1016\/j.brainres.2018.08.022_b0150","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/emmm.200900051","article-title":"Neurodegenerative diseases: lessons from genome-wide screens in small model organisms","volume":"1","author":"Van Ham","year":"2009","journal-title":"EMBO Mol. Med."},{"issue":"9","key":"10.1016\/j.brainres.2018.08.022_b0155","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3109\/1061186X.2015.1020808","article-title":"Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET","volume":"23","author":"Xu","year":"2015","journal-title":"J. Drug Target."},{"issue":"9","key":"10.1016\/j.brainres.2018.08.022_b0160","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00432-014-1701-8","article-title":"Insulinoma imaging with glucagon-like peptide-1 receptor targeting probe (18)F-FBEM-Cys (39)-exendin-4","volume":"140","author":"Xu","year":"2014","journal-title":"J. Cancer Res. Clin."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318304451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318304451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T17:58:27Z","timestamp":1757786307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899318304451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":32,"alternative-id":["S0006899318304451"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2018.08.022","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-related change of GLP-1R expression in rats can be detected by [18F]AlF-NOTA-MAL-Cys39-exendin-4","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2018.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}